Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
1h
Asian News International on MSNEli Lilly launches Mounjaro in India for anti obesity treatmentGlobal pharmaceutical company Eli Lilly and Company (India) has introduced Mounjaro (tirzepatide) in India, a breakthrough drug for the treatment of Type 2 diabetes and obesity. Approved by the ...
Global demand for Lilly's diabetes and weight-loss drugs has soared, with the launch presenting a big market opportunity for the US-based drug company as India, world's most populous country, is ...
(Reuters) - Eli Lilly (LLY) is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage trial by recording nearly $550 million in "pre-launch inventory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results